Medpace Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,782	2,530	2,109	1,886	1,460	1,142
Revenue Growth (YoY)	24.67%	19.97%	11.84%	29.17%	27.80%	23.38%
Cost of Revenue	1,982	1,770	1,453	1,361	1,028	814.22
Gross Profit	800.22	760.62	656.31	524.51	432.44	328.16
Selling, General & Admin	189.02	197.56	180.18	161.35	131.4	108.42
Depreciation & Amortization Expenses	27.8	28.12	29.25	26.33	22.34	21.12
Total Operating Expenses	216.81	225.68	209.44	187.68	153.74	129.54
Operating Income	583.4	534.94	446.87	336.83	278.7	198.62
Interest Income	15.34	12.78	25	-0.49	-2.91	-0.11
Other Non-Operating Income (Expense)	0.18	-5.34	4.06	-0.66	7.07	3.34
Total Non-Operating Income (Expense)	15.52	7.44	29.05	-1.14	4.16	3.24
Pretax Income	598.92	542.38	475.92	335.68	282.86	201.85
Provision for Income Taxes	107.42	91.25	71.54	52.87	37.49	20
Net Income	491.5	451.12	404.39	282.81	245.37	181.85
Net Income to Common	491.5	451.12	404.39	282.81	245.37	181.85
Net Income Growth	17.50%	11.56%	42.99%	15.26%	34.93%	25.08%
Shares Outstanding (Basic)	28	29	31	31	32	36
Shares Outstanding (Diluted)	29	30	32	32	34	38
Shares Change (YoY)	-7.24%	-7.77%	0.54%	-5.44%	-10.68%	-0.03%
EPS (Basic)	17.39	15.64	13.06	9.20	7.57	5.06
EPS (Diluted)	17.06	15.28	12.63	8.88	7.28	4.81
EPS Growth	26.84%	20.98%	42.23%	21.98%	51.35%	25.26%
Free Cash Flow	706.69	681.87	572.27	396.73	351.17	235.06
Free Cash Flow Growth	3.64%	19.15%	44.25%	12.97%	49.40%	3.40%
Free Cash Flow Per Share	24.52	23.09	17.88	12.46	10.43	6.24
Gross Margin	28.76%	30.06%	31.12%	27.81%	29.62%	28.73%
Operating Margin	20.97%	21.14%	21.19%	17.86%	19.09%	17.39%
Profit Margin	17.67%	17.83%	19.17%	15.00%	16.81%	15.92%
FCF Margin	25.40%	26.95%	27.13%	21.04%	24.05%	20.58%
EBITDA	611.2	563.06	476.12	363.15	301.04	219.73
EBITDA Margin	21.97%	22.25%	22.58%	19.26%	20.62%	19.23%
EBIT	583.4	534.94	446.87	336.83	278.7	198.62
EBIT Margin	20.97%	21.14%	21.19%	17.86%	19.09%	17.39%
Effective Tax Rate	17.94%	16.82%	15.03%	15.75%	13.25%	9.91%

SEC Filings: 10-K · 10-Q